Women are disproportionately affected by depressive disorders relative to men, and mid-life differences like menopause can exacerbate symptoms. Hormone therapy (HT) is a common treatment to ease menopause transitions, including vasomotor and depressive symptoms, that may occur due to menopause-related hormonal ch...
Kelly A. Lopez Garcia, H. Klinger, Catherine E. Munro et al.· BMC Medicine· 0 citations
Background: Blood-based biomarkers (BBMs) may facilitate early detection of Alzheimers disease (AD), yet data in Latino populations remain limited. We examined associations of plasma biomarkers with cognition and depressive symptoms in Spanish-speaking Latino older adults enrolled in the Boston Latino Aging Study (BLAS...
C. Tristão-Pereira, G. Silva, K. Lopez et al.· medRxiv· 0 citations
Abstract INTRODUCTION Vitamin D3 and omega‐3 supplementation may slow outcomes related to Alzheimer's disease and related dementias (ADRD), with variation by sex or race, but their effects on ADRD‐associated biomarkers are unknown. METHODS In this secondary analysis of a randomized clinical trial (RCT), we included 929...
Chirag M. Vyas, B. Ostaszewski, A. K. Anderson et al.· Alzheimer's & Dementia· 0 citations
It is revealed that mild behavioral impairment symptoms may emerge before cognitive decline in ADAD and supports the MBI‐C as a tool for detecting early behavioral changes linked to AD pathology and identifying at‐risk individuals for clinical trials and early intervention.
Catarina Tristão-Pereira, D. Vásquez, Jorge Alcina et al.· Alzheimer's & Dementia· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
